Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17809396 | 1.00 | ATM (0.41) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL18593795 | 1.00 | ATM (0.41) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL18124909 | 1.00 | ATM (0.41) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL26052765 | 1.00 | ATM (0.41) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL26052748 | 0.99 | ATM (0.42) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL24550378 | 0.97 | L3MBTL1 (0.45) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL17189507 | 0.97 | L3MBTL1 (0.45) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL16522992 | 0.97 | L3MBTL1 (0.45) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL21365848 | 0.97 | L3MBTL1 (0.45) | ATMKDM4EL3MBTL1HDAC4KMT2A | |
| SCHEMBL18593797 | 0.97 | L3MBTL1 (0.45) | ATMKDM4EL3MBTL1HDAC4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230363190-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230363190-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230276704-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230276704-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-08-31 | — | — | US | disclosed |
| EP-4234556-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL Chemical & Material Co., Ltd. (JP) | 2023-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230276704-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | ETV6, IKZF2, EML4 | ATM 4641/4885KDM4E 380/4885L3MBTL1 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.